1.Androgen and prostatic stroma.
Yuan-Jie NIU ; Teng-Xiang MA ; Ju ZHANG ; Yong XU ; Rui-Fa HAN ; Guang SUN
Asian Journal of Andrology 2003;5(1):19-26
AIMTo investigate the effect of androgen on the proliferation, differentiation and regression of canine prostatic stromal cells in vivo and human stromal cells in vitro.
METHODSTwenty-two dogs, including 15 normal prostate dogs and 7 prostatic hyperplasia dogs, had their serum concentration of testosterone and estrodiol determined by radioimmunoassay before and after castration. The expression of androgen receptor (AR) and estrogen receptor (ER) in the prostate were analysed by immunohistochemistry and semi-quantitative RT-PCR before and after castration. Light microscopy, transmission electron microscopy and TUNEL assay were carried out successively before and after castration to evaluate the prostatic histomorphology. In vitro serum-free cell cultures from human prostatic stroma were established and exposed to dihydrotestosterone (DHT). The proliferation of the cell culture was detected by MTT assay. The expression of TGFbgr, bFGF, AR, and smooth muscle cell (SMC) specific proteins (myosin and/or smoothelin) were detected using immunohistochemistry and RT-PCR. The differentiation from fibroblasts to smooth muscle cells was deduced by measuring the expression of SMC specific proteins.
RESULTSBefore castration, the serum concentrations of testosterone and estrodiol were not statistically different between normal and hyperplasia groups. Following castration, the serum concentration of testosterone decreased rapidly in 2 days, and the concentration of estrodiol had no significant change compared with the pre-castration data. In the prostate, AR was presented in both the epithelial and stromal cells and the AR mRNA level was higher in hyperplasia than in normal prostate tissues (P<0.05). While ER predominantly existed in the prostate stromal cells and the ER mRNA had no difference between the hyperplasia and the normal group. Within the early phase of castration ( CONCLUSIONThe whole prostate gland is an androgen-sensitive organ with both the epithelium and stroma under the control of androgen. Androgen may direct the proliferation, differentiation and regression of stromal cells by regulating the expression of TGFbgr, bFGF, AR and smooth muscle cell specific proteins.
Animals
;
Biomarkers
;
Cell Differentiation
;
drug effects
;
physiology
;
Cell Division
;
drug effects
;
physiology
;
Cells, Cultured
;
Dihydrotestosterone
;
pharmacology
;
Dogs
;
Estradiol
;
blood
;
Fibroblast Growth Factor 2
;
genetics
;
pharmacology
;
Gene Expression
;
Humans
;
Male
;
Muscle, Smooth
;
cytology
;
physiology
;
Orchiectomy
;
Prostate
;
cytology
;
physiology
;
Prostatic Hyperplasia
;
physiopathology
;
RNA, Messenger
;
analysis
;
Receptors, Androgen
;
genetics
;
Receptors, Estrogen
;
genetics
;
Stromal Cells
;
cytology
;
physiology
;
Testosterone
;
blood
;
Transforming Growth Factor beta
;
genetics
;
pharmacology
2.Spatiotemporal regulation of fibroblast growth factor signal blocking for endoderm formation in Xenopus laevis.
Sang wook CHA ; Jong Woo LEE ; Yoo seok HWANG ; Jeong Pil CHAE ; Kwon Moo PARK ; Hee Jung CHO ; Dong Sun KIM ; Yong Chul BAE ; Mae Ja PARK
Experimental & Molecular Medicine 2008;40(5):550-557
We have previously shown that the inhibition of fibroblast growth factor (FGF) signaling induced endodermal gene expression in the animal cap and caused the expansion of the endodermal mass in Xenopus embryos. However, we still do not know whether or not the alteration of FGF signaling controls embryonic cell fate, or when FGF signal blocking is required for endoderm formation in Xenopus. Here, we show that FGF signal blocking in embryonic cells causes their descendants to move into the endodermal region and to express endodermal genes. It is also interesting that blocking FGF signaling between fertilization and embryonic stage 10.5 promotes endoderm formation, but persistent FGF signaling blocking after stage 10.5 restricts endoderm formation and differentiation.
Animals
;
Endoderm/drug effects/embryology/*metabolism
;
Fibroblast Growth Factors/antagonists & inhibitors/genetics/*physiology
;
Gene Expression Regulation, Developmental/drug effects
;
In Situ Hybridization
;
Pyrroles/administration & dosage/pharmacology
;
Receptors, Fibroblast Growth Factor/genetics/physiology
;
Reverse Transcriptase Polymerase Chain Reaction
;
Signal Transduction/drug effects
;
Xenopus Proteins/antagonists & inhibitors/genetics/*physiology
;
Xenopus laevis/embryology/genetics/*physiology
3.Porcine vesical acellular matrix graft of tunica albuginea for penile reconstruction.
Kwan-Joong JOO ; Byung-Soo KIM ; Jeong-Ho HAN ; Chang-Ju KIM ; Chil-Hun KWON ; Heung-Jae PARK
Asian Journal of Andrology 2006;8(5):543-548
AIMTo characterize the feasibility of the surgical replacement of the penile tunica albuginea (TA) and to evaluate the value of a porcine bladder acellular matrix (BAM) graft.
METHODSAcellular matrices were constructed from pigs' bladders by cell lysis, and then examined by scanning electron microscopy (SEM). Expression levels of the mRNA of the vascular endothelial growth factor (VEGF) receptor, fibroblast growth factor (FGF)-1 receptor, neuregulin, and brain-derived neurotrophic factor (BDNF) in the acellular matrix and submucosa of the pigs'bladders were determined through the reverse transcription-polymerase chain reaction (PCR). A 5 mm X 5 mm square was excised from the penile TA of nine rabbits. The defective TA was then covered in porcine BAM. Equal numbers of animals were sacrificed and histochemically examined at 2, 4 and 6 months after implantation.
RESULTSSEM of the BAM showed collagen fibers with many pores. VEGF receptor, FGF-1 receptor and neuregulin mRNA were expressed in the porcine BAM; BDNF mRNA was not detected. Two months after implantation, the graft sites exhibited excellent healing without contracture, and the fusion between the graft and the neighboring normal TA appeared to be well established. There were no significant histological differences between the implanted tunica and the normal control tunica at 6 months after implantation.
CONCLUSIONThe porcine BAM graft resulted in a structure which was sufficiently like that of the normal TA. This implantation might be considered applicable to the reconstruction of the TA in conditions such as trauma or Peyronie's disease.
Animals ; Brain-Derived Neurotrophic Factor ; genetics ; Cyclophilins ; genetics ; Disease Models, Animal ; Male ; Microscopy, Electron, Scanning ; Neuregulins ; genetics ; Penis ; surgery ; Polymerase Chain Reaction ; Receptors, Fibroblast Growth Factor ; genetics ; Receptors, Vascular Endothelial Growth Factor ; genetics ; Reconstructive Surgical Procedures ; Surgery, Plastic ; Swine ; Urinary Bladder ; physiology ; surgery ; ultrastructure
4.Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor.
Rui-zhe QIAN ; Fei YUE ; Guo-ping ZHANG ; Li-kun HOU ; Xin-hong WANG ; Hui-ming JIN
Chinese Medical Journal 2008;121(24):2599-2603
BACKGROUNDThe level of basic fibroblast growth factor (bFGF) increases rapidly after cerebral ischemia. However, the molecular mechanisms for the effects of bFGF on cerebral microvascular endothelial cells (cMVECs) have not yet been fully elucidated. In this study, a murine cMVEC line, bEnd.3, was employed to study the effects of bFGF on cyclooxygenase (COX) expression and its downstream effects in cMVECs.
METHODSAfter treatment with bFGF, RT-PCR and Western blotting analyses were carried out to evaluate the changes in COX-2 mRNA and protein expression, respectively. MTT assays were performed to measure cell proliferation. The prostaglandin E2 (PGE2) and vascular endothelial growth factor (VEGF) concentrations in the culture medium were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTSCOX-2 mRNA and protein expressions in bEnd.3 cells were induced by bFGF in time- and dose-dependent manners. The bFGF-induced COX-2 upregulation led to enhanced PGE2 production by bEnd.3 cells, and this effect was abolished by the selective COX-2 inhibitor NS-398. bFGF also increased VEGF production by bEnd.3 cells, and this effect was blocked by NS-398 and the EP1/2 (PGE2 receptors) antagonist AH6809. Furthermore, exogenous PGE2 increased VEGF production in bEnd.3 cells, and AH6809 blocked this effect.
CONCLUSIONbFGF increases VEGF production in an autocrine manner by increasing COX-2-generated PGE2 in cMVECs and subsequently stimulates MVEC proliferation and angiogenesis.
Blotting, Western ; Cell Line ; Cell Proliferation ; drug effects ; Cyclooxygenase 2 ; genetics ; metabolism ; physiology ; Dinoprostone ; metabolism ; pharmacology ; Endothelial Cells ; cytology ; drug effects ; metabolism ; Enzyme-Linked Immunosorbent Assay ; Fibroblast Growth Factor 2 ; pharmacology ; Humans ; Receptors, Prostaglandin E ; antagonists & inhibitors ; Reverse Transcriptase Polymerase Chain Reaction ; Vascular Endothelial Growth Factor A ; metabolism ; Xanthones ; pharmacology